| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| ipilimumab prescribing information | 1.45 | 0.1 | 4622 | 47 | 34 |
| ipilimumab | 2 | 0.3 | 4796 | 55 | 10 |
| prescribing | 0.45 | 0.9 | 5039 | 72 | 11 |
| information | 0.19 | 0.2 | 6335 | 30 | 11 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| ipilimumab prescribing information | 0.16 | 0.2 | 6726 | 98 |
| ipilimumab prescribing information 2022 | 1.65 | 0.4 | 2067 | 99 |
| ipilimumab and fda indications | 1.91 | 0.5 | 9662 | 51 |
| ipilimumab fda approval history | 0.71 | 0.8 | 7193 | 87 |
| ipilimumab cost per dose | 1.31 | 0.7 | 1129 | 81 |
| ipilimumab cost in india | 2 | 0.2 | 7449 | 76 |
| injection ipilimumab 1 mg | 1.47 | 0.5 | 2842 | 42 |
| ipilimumab product monograph canada | 0.89 | 0.9 | 4986 | 92 |
| cpt code for ipilimumab | 0.73 | 1 | 8400 | 36 |
| ipilimumab cancer research uk | 1.08 | 0.5 | 7502 | 27 |
| ipilimumab nivolumab combination fda approval | 1.39 | 1 | 5931 | 92 |
| ipilimumab failed indications due to safety | 1.06 | 0.4 | 2137 | 93 |
| ipilimumab and nivolumab patient information | 0.98 | 0.2 | 6492 | 64 |
| ipilimumab patent expiry date | 1.76 | 0.9 | 4032 | 73 |
| how is ipilimumab administered | 0.29 | 0.6 | 9128 | 77 |
| ipilimumab + nivolumab | 1.02 | 0.3 | 2398 | 93 |
| side effects of ipilimumab | 1.11 | 0.4 | 424 | 55 |
| ipilimumab and nivolumab regimen | 1.05 | 0.5 | 469 | 67 |
| ipilimumab scheda tecnica aifa | 1.73 | 0.6 | 9423 | 96 |
| ipilimumab scheda tecnica ema | 1.2 | 0.4 | 7567 | 7 |
